期刊
ANNUAL REVIEW OF MICROBIOLOGY
卷 61, 期 -, 页码 35-50出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev.micro.61.111606.122346
关键词
enoyl-reductase; ethionamide; prodrug; resistance; tuberculosis
类别
资金
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043268, R21AI043268, P01AI068135] Funding Source: NIH RePORTER
- NIAID NIH HHS [AI068135, AI43268] Funding Source: Medline
Isoniazid (INH) is one of the most efficient drugs for the treatment of Mycobacterium tuberculosis infections. Despite its rather simple chemical structure, the mechanism by which INH kills M. tuberculosis is complex. A full understanding of the mechanisms of action of INH required the development of genetic tools in M. tuberculosis. Herein, we discuss the different hypotheses that have been used to describe INH action against M. tuberculosis over the past 50 years in terms of the pregenetic and genetic era. We also review the different mechanisms of 12,INH resistance and propose what we think is the means by which INH kills M. tuberculosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据